Novo Holdings-backed Booster takes off with protein degraders aimed at neurodegeneration
Pfizer's cancer drug combo improves overall survival in late-stage study
How Madrigal plans to win on the market with the first MASH drug
Inflation Reduction Act proves positive boost for biosimilars
*please scroll down for all the latest news*
